Alpha 2.0
Login Register
» Articles » PMID: 27088541

Patient-reported Adherence and Persistence to Topical Treatments for Actinic Keratosis: a Longitudinal Diary Study

Overview
Journal Br J Dermatol
Publisher Oxford University Press
Specialty Dermatology
Date 2016 Apr 19
PMID 27088541
Citations 4
Authors
S Erntoft
J M Norlin
C Pollard
T L Diepgen
Affiliations
Soon will be listed here.
Citing Articles

Poor Adherence to Self-Applied Topical Drug Treatment Is a Common Source of Low Lesion Clearance in Patients with Actinic Keratosis-A Cross-Sectional Study.

Koch E, Steeb T, Bender-Sabelkampf S, Busch D, Feustel J, Kaufmann M J Clin Med. 2023; 12(11).

PMID: 37298008 PMC: 10253365. DOI: 10.3390/jcm12113813.

Contact Sensitization and Phototoxic and Photoallergic Potential of Tirbanibulin 1% Ointment in Healthy Volunteers.

Dosik J, Cutler D, Fang J, Padulles L JID Innov. 2023; 3(2):100170.

PMID: 36699198 PMC: 9868847. DOI: 10.1016/j.xjidi.2022.100170.

Comparative Efficacy and Safety of Tirbanibulin for Actinic Keratosis of the Face and Scalp in Europe: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.

Heppt M, Dykukha I, Graziadio S, Salido-Vallejo R, Chapman-Rounds M, Edwards M J Clin Med. 2022; 11(6).

PMID: 35329979 PMC: 8952421. DOI: 10.3390/jcm11061654.

Pharmacoeconomic Considerations in Treating Actinic Keratosis: An Update.

Vale S, Hill D, Feldman S Pharmacoeconomics. 2016; 35(2):177-190.

PMID: 27785771 DOI: 10.1007/s40273-016-0462-4.